# MONITOR Product Roadmap

## Vision

**Make clinical-grade health inference accessible to every application.**

---

## Q1 2026 (Current)

### âœ… Phase 1: Foundation (Complete)
- [x] Core inference engine
- [x] 20+ biomarker support
- [x] Confidence scoring system
- [x] API design and documentation
- [x] Clinical data verification
- [x] Demo application

### ðŸ”„ Phase 2: Launch (In Progress)
- [x] Public demo site
- [x] Investor materials
- [ ] Production API deployment
- [ ] Beta user onboarding
- [ ] First clinic pilots

---

## Q2 2026

### Phase 3: Scale
- [ ] 50+ biomarker support
- [ ] Complete metabolic panel
- [ ] Complete blood count
- [ ] Hormone panels (thyroid, sex hormones, cortisol)
- [ ] PDF lab upload parsing
- [ ] Mobile app (iOS, Android)

### Phase 4: Intelligence
- [ ] Trend analysis and tracking
- [ ] Personalized baseline detection
- [ ] ML-enhanced pattern recognition
- [ ] Risk trajectory forecasting

---

## Q3 2026

### Phase 5: Integration
- [ ] EHR integration (FHIR, HL7)
- [ ] Wearable data fusion (Oura, Whoop, Apple Watch)
- [ ] CGM data integration (Dexcom, Libre)
- [ ] Lab network partnerships (Quest, Labcorp)

### Phase 6: Enterprise
- [ ] Multi-tenant architecture
- [ ] Custom model training
- [ ] On-premise deployment option
- [ ] SOC 2 Type II certification
- [ ] HIPAA compliance package

---

## Q4 2026

### Phase 7: Expansion
- [ ] International reference ranges
- [ ] Multi-language support
- [ ] EU market entry
- [ ] Regulatory pathway assessment (FDA 510k)

### Phase 8: Platform
- [ ] Developer SDK (Python, JavaScript)
- [ ] Webhook event system
- [ ] Custom inference rules
- [ ] White-label solution

---

## 2027 Goals

- **Users:** 100,000+ active
- **ARR:** $5M+
- **Enterprise:** 20+ customers
- **Biomarkers:** 100+
- **Specimens:** Blood, urine, saliva, sweat, ISF
- **Team:** 15-20 people

---

## Feature Prioritization

### P0 (Critical)
- Production API stability
- Core biomarker accuracy
- Security and compliance

### P1 (High)
- New biomarker coverage
- Trend analysis
- Mobile apps

### P2 (Medium)
- EHR integration
- Wearable data
- Enterprise features

### P3 (Nice to Have)
- International expansion
- Custom models
- Advanced ML

---

## Technical Milestones

| Milestone | Target | Status |
|-----------|--------|--------|
| 1M API calls | Q2 2026 | Pending |
| 99.9% uptime | Q2 2026 | Pending |
| <100ms latency | Q2 2026 | Pending |
| SOC 2 Type I | Q3 2026 | Pending |
| SOC 2 Type II | Q4 2026 | Pending |

---

## Research Initiatives

### Active
- Multi-biomarker interaction modeling
- Confidence calibration studies
- Population stratification analysis

### Planned
- Clinical outcome correlation study
- Provider usability research
- Patient comprehension testing

---

## Open Questions

1. **Regulatory:** Optimal pathway for Clinical Decision Support classification
2. **Pricing:** B2B pricing optimization based on market feedback
3. **Partnerships:** Strategic vs. distribution partnerships priority
4. **International:** EU vs. other markets for initial expansion

---

*Roadmap updated: February 2, 2026*
*Next review: March 2026*
